London
10 °C
Manchester
Glasgow
3 °C
Dublin
9 °C
Belfast
Washington
0 °C
Denver
Atlanta
Dallas
Houston Texas
New Orleans
El Paso
Phoenix
Los Angeles
4 °C
-17 °C
22 °C
30 °C
20 °C
30 °C
Join NDT Pharmaceuticals' Exclusive Live Investor Webinar and Q&A Session on November 5
NYSE - LSE
| RBGPF | 0% | 78.35 | $ | |
| JRI | 0.29% | 13.79 | $ | |
| BCC | -1.66% | 73.05 | $ | |
| CMSD | -0.3% | 23.25 | $ | |
| SCS | -0.56% | 16.14 | $ | |
| NGG | -0.66% | 75.41 | $ | |
| RELX | -0.55% | 40.32 | $ | |
| GSK | -0.33% | 48.41 | $ | |
| CMSC | -0.21% | 23.43 | $ | |
| RYCEF | -0.34% | 14.62 | $ | |
| RIO | -0.92% | 73.06 | $ | |
| VOD | -1.31% | 12.47 | $ | |
| AZN | 0.17% | 90.18 | $ | |
| BCE | 1.4% | 23.55 | $ | |
| BTI | -1.81% | 57.01 | $ | |
| BP | -3.91% | 35.83 | $ |
Join NDT Pharmaceuticals' Exclusive Live Investor Webinar and Q&A Session on November 5
ORLANDO, FLORIDA / ACCESS Newswire / October 30, 2025 / RedChip Companies will host an investor webinar with NDT Pharmaceuticals Inc. (OTC PINK:NDTP), a company focused on advancing innovative consumer health and wellness solutions, on November 5, 2025, at 4:15 p.m. ET.
The exclusive event will feature NDT Pharmaceuticals' President and CEO, Zach O'Shea, who will share insights into how NDT Pharmaceuticals is redefining biosafety and infection control through its wholly owned subsidiary, Good Salt Life. The company's vertically integrated platform combines proprietary chemical delivery technology, EPA-approved antimicrobial solutions, and data-driven disinfection protocols to create sustainable, science-backed ecosystems that protect people, pets, and the planet. O'Shea will highlight the company's strategic partnership with a leading animal health company, which expands Good Salt Life's global footprint across livestock, aquaculture, and companion animal markets, as well as deployments with marquee clients including United Airlines, Carnival Cruise Line, Marriott, and the NFL. With a $148 billion total addressable market and projected revenue growth from $2.4 million in 2025 to $500 million by 2030, NDT Pharmaceuticals is positioned as a high-growth, category-defining player in the health, safety, and wellness industry.
A live question and answer session will follow the presentation.
To register for the free webinar, please visit: https://www.redchip.com/webinar/NDTP/82713029276
Questions can be pre-submitted to [email protected] or online during the live event.
About NDT Pharmaceuticals, Inc. (OTC PINK:NDTP)
NDT Pharmaceuticals, Inc. is a publicly traded company focused on advancing innovative consumer health and wellness solutions. Through its subsidiary, Good Salt Life, the Company has expanded its strategic direction into sustainable, science-driven products that promote healthier living. The Company is committed to building value through investments in sustainable, science-driven brands that protect people, pets, and the planet while aligning with growing consumer demand for eco-friendly and health-conscious alternatives.
About Good Salt™ Life, Inc.
Good Salt Life is dedicated to promoting vitality through eco-friendly, nature-derived products that support healthier living environments. With a focus on innovation and sustainability, the company offers safe and effective solutions for home, pet, personal care, and animal health. Through strategic partnerships, including collaborations in the B2B animal health sector, Good Salt Life continues to drive advancements that benefit both people and animals. For more information, visit www.goodsaltlife.com.
About RedChip Companies
RedChip Companies, an Inc. 5000 company, is an international investor relations, media, and research firm focused on microcap and small-cap companies. For 33 years, RedChip has delivered concrete, measurable results for its clients. Our newsletter, Small Stocks, Big Money™, is delivered online weekly to 60,000 investors. RedChip has developed the most comprehensive service platform in the industry for microcap and small-cap companies. These services include the following: a worldwide distribution network for its stock research; retail and institutional roadshows in major U.S. cities; outbound marketing to stock brokers, RIAs, institutions, and family offices; a digital media investor relations platform that has generated millions of unique investor views; investor webinars and group calls; a television show, Small Stocks, Big Money™, which airs weekly on Bloomberg US; TV commercials in local and national markets; corporate and product videos; website design; and traditional investor relation services, which include press release writing, development of investor presentations, quarterly conference call script writing, strategic consulting, capital raising, and more. RedChip also offers RedChat™, a proprietary AI-powered chatbot that analyzes SEC filings and corporate disclosures for all Nasdaq and NYSE-listed companies, giving investors instant, on-demand insights.
To learn more about RedChip's products and services, please visit: https://www.redchip.com/corporate/investor_relations
"Discovering Tomorrow's Blue Chips Today"™
Follow RedChip on LinkedIn: https://www.linkedin.com/company/redchip/
Follow RedChip on Facebook: https://www.facebook.com/RedChipCompanies
Follow RedChip on Instagram: https://www.instagram.com/redchipcompanies/
Follow RedChip on Twitter: https://twitter.com/RedChip
Follow RedChip on YouTube: https://www.youtube.com/@redchip
Follow RedChip on Rumble: https://rumble.com/c/c-3068340
Subscribe to our Mailing List: https://www.redchip.com/newsletter/latest
Contact:
Dave Gentry
RedChip Companies, Inc.
1-800-REDCHIP (733-2447)
1-407-644-4256
[email protected]
SOURCE: RedChip Companies, Inc.
View the original press release on ACCESS Newswire
(A.Johnson--TAG)
